Glaukos GKOS
NYSE GKOS
$158.25 -0.31 (-0.20%)
As of: Sep 29, 2026 · 3:59 PM EDT

Glaukos (GKOS) EV to EBITDA (2016 - 2022)

Updated

Glaukos' (GKOS) EV to EBITDA was 95.45 for Q2 2022, down 88.4% from 822.83 a year earlier but up 58.8% from the prior quarter.

Analysis

Glaukos (GKOS) EV to EBITDA (2016 - 2022) Analysis & Trends

Over the twelve months ended Jun 30, 2022, Glaukos' EV to EBITDA came in at 80.56, down 89.5% year-over-year; for FY2021, it was 91.54.

  • By year, EV to EBITDA came in at 269.75 in FY2017 (+108.8%).
  • Five-year quarterly EV to EBITDA spans a low of 60.11 in Q1 2022 and a high of 822.83 in Q2 2021.
  • Per Business Quant data, the three quarters before Q2 2022 came in at 60.11 (Q1 2022), 91.54 (Q4 2021) and 76.38 (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Glaukos 9.33 Bn 8.92 Bn 151.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 95.45
Mar 31, 2022 60.11
Dec 31, 2021 91.54
Sep 30, 2021 76.38
Jun 30, 2021 822.83
Dec 31, 2017 269.75
Sep 30, 2017 385.48
Jun 30, 2017 499.49
Mar 31, 2017 205.08
Dec 31, 2016 129.17
Sep 30, 2016 200.46
Jun 30, 2016 279.36
API Access

Glaukos EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GKOS&period=max&api_key=YOUR_API_KEY